Alkermes

E148148

Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (2)

Label Occurrences
Alkermes canonical 1
Alkermes Pharma Ireland Limited 1

Statements (42)

Predicate Object
instanceOf biopharmaceutical company
public company
businessModel partnership-based drug development
research and development of proprietary medicines
chairman Richard Pops
chiefExecutiveOfficer Richard Pops
collaboratesWith major pharmaceutical companies
country United States of America
surface form: United States
develops biologic therapies
small-molecule drugs
focusesOn central nervous system disorders
serious chronic diseases
foundedBy Michael Wall
Richard Pops
hasManufacturingFacility Athlone
surface form: Athlone, Ireland

Wilmington, Ohio
hasOperationalHeadquarters Waltham, Massachusetts NERFINISHED
hasSubsidiary Alkermes self-linksurface differs
surface form: Alkermes Pharma Ireland Limited
headquartersCountry Ireland
headquartersLocation Dublin
industry biotechnology
pharmaceuticals
listedOn Nasdaq Global Select Market
surface form: NASDAQ Global Select Market
product Aristada
Aristada
surface form: Aristada Initio

Vivitrol
regionServed global
regulatoryEnvironment EMA-regulated
FDA-regulated
researchFocus immuno-oncology
neuroscience
specializesIn drug delivery technologies
long-acting injectable formulations
stockExchange NASDAQ
targetPatientGroup patients with addiction disorders
patients with psychiatric disorders
therapeuticArea alcohol dependence
bipolar disorder
major depressive disorder
opioid dependence
schizophrenia
tickerSymbol ALKS

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Vumerity developedBy Alkermes
Alkermes hasSubsidiary Alkermes self-linksurface differs
this entity surface form: Alkermes Pharma Ireland Limited